Literature DB >> 11678726

G protein-coupled receptor signalling in in vivo cardiac overload.

A Rapacciuolo1, G Esposito, S V Prasad, H A Rockman.   

Abstract

Cardiac myocytes respond to biomechanical stress by initiating cellular processes that lead to hypertrophy. Although cardiac hypertrophy is a response to increased stress on the heart, it is associated with elevated plasma catecholamine levels and an increase in cardiac morbidity and mortality. Understanding the cellular signals that initiate the hypertrophic response will be of critical importance to identify pathways that mediate the maladaptive deterioration of the hypertrophic heart to one of cardiac failure. This review will focus on the role of G protein-coupled receptors in the activation of signalling pathways in the heart, such as the mitogen activated protein kinase and phosphoinositide-3 kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678726     DOI: 10.1046/j.1365-201X.2001.00884.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  3 in total

1.  Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.

Authors:  Stacey L House; Brian E House; Betty Glascock; Thomas Kimball; Eyad Nusayr; Jo El J Schultz; Thomas Doetschman
Journal:  Mol Cell Pharmacol       Date:  2010

2.  Attenuation of changes in G(i)-proteins and adenylyl cyclase in heart failure by an ACE inhibitor, imidapril.

Authors:  R Sethi; Q Shao; N Takeda; N S Dhalla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

3.  APJ acts as a dual receptor in cardiac hypertrophy.

Authors:  Maria Cecilia Scimia; Cecilia Hurtado; Saugata Ray; Scott Metzler; Ke Wei; Jianming Wang; Chris E Woods; Nicole H Purcell; Daniele Catalucci; Takeshi Akasaka; Orlando F Bueno; George P Vlasuk; Perla Kaliman; Rolf Bodmer; Layton H Smith; Euan Ashley; Mark Mercola; Joan Heller Brown; Pilar Ruiz-Lozano
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.